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Abstract
Background: It is well established that cancer cells can fuse with endothelial cells to form hybrid cells spontaneously,
which facilitates cancer cells traversing the endothelial barrier to form metastases. However, up to now, little is known
about the biologic characteristics of hybrid cells. Therefore, we investigate the malignant biologic behaviors and proteins
expression of the hybrid cell line EAhy926 with its parent cell line A549.
Methods: Cell counting and flow cytometry assay were carried out to assess cell proliferation. The number of cells
attached to the extracellular matrix (Matrigel) was measured by MTT assay for the adhesion ability of cells. Transwell
chambers were established for detecting the ability of cell migration and invasion. Tumor xenograft test was carried out
to observe tumorigenesis of the cell lines. In addition, two-dimensional electrophoresis (2-DE) and mass spectrometry
were utilized to identify differentially expressed proteins between in Eahy926 cells and in A549 cells.
Results: The doubling time of EAhy926 cell and A549 cell proliferation was 25.32 h and 27.29 h, respectively (P > 0.1).
Comparing the phase distribution of cell cycle of EAhy926 cells with that of A549 cells, the percentage of cells in G0/G1
phase, in S phase and in G2/M phase was (63.7% ± 2.65%) VS (60.0% ± 3.17%), (15.4% ± 1.52%) VS (13.8% ± 1.32%), and
(20.9% ± 3.40%) VS (26.3% ± 3.17%), respectively (P > 0.05). For the ability of cell adhesion of EAhy926 cells and A549
cells, the value of OD in Eahy926 cells was significantly higher than that in A549 cells (0.3236 ± 0.0514 VS 0.2434 ±
0.0390, P < 0.004). We also found that the migration ability of Eahy926 cells was stronger than that of A549 cells (28.00
± 2.65 VS 18.00 ± 1.00, P < 0.01), and that the invasion ability of Eahy926 cells was significantly weak than that of A549
cells (15.33 ± 0.58 VS 26.67 ± 2.52, P < 0.01). In the xenograft tumor model, expansive masses of classic tumor were
found in the A549 cells group, while subcutaneous inflammatory focuses were found in the EAhy926 cells group. Besides,
twenty-eight proteins were identified differentially expressed between in EAhy926 cells and in A549 cells by proteomics
technologies.
Conclusion: As for the biological behaviors, the ability of cell proliferation in Eahy926 cells was similar to that in A549
cells, but the ability in adhesion and migration of Eahy926 cells was higher. In addition, Eahy926 cells had weaker ability
in invasion and could not form tumor mass. Furthermore, there were many differently expressed proteins between
hybrid cell line Eahy926 cells and A549 cells, which might partly account for some of the differences between their
biological behaviors at the molecular level. These results may help to understand the processes of tumor angiogenesis,
invasion and metastasis, and to search for screening method for more targets for tumor therapy in future.
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Introduction
Angiogenesis plays a critical role in the growth and pro-
gression of solid tumors. Traditionally, it is regarded that
tumor vascular wall is composed of only vein endothelial
cells. However, this view has been being subjected to chal-
lenges recently. Several indirect and direct evidences
showed that endothelial cells and tumor cells can form
"mosaic" vessels [1,2]. For example, human colon cancer
cells were shown to contribute a proportion of the vessel
surface in tumors grown orthotopically in mice. Even
aggressive melanoma cells were found to generate vascu-
lar channels independently that facilitate tumor invasion.
Cancer cells could fuse with endothelial cells to form
hybrid cells both in vitro and in vivo, expressing parent
proteins and chromosomal markers. The occurrence of
endothelial cell markers facilitated escape of immune sur-
veillance and clearance of the host, while the produced
proteases continuously degraded the vascular basement
membrane [3,4]. Therefore, studies on the cancer-
endothelial hybrid cells are helpful in understanding the
processes of tumor angiogenesis, invasion and metastasis.
Human endothelial-like Eahy926 cell line was derived
from fusion of human umbilical vein endothelial cells
with human lung adenocarcinoma cell line A549 [5,6]. In
this study, malignant biological behaviors of hybrid cell
line Eahy926 were investigated by comparing it to its par-
ent cell line A549, involving in their proliferation, adhe-
sion, invasion, migration and tumorigenesis. Meantime,
28 differentially expressed proteins were identified
between Eahy926 cells and A549 cells. Moreover, some
biological behaviors of Eahy926 cells were elucidated at
the protein level. These data provided evidences for inter-
actions of cancer cells with endothelial cells, and were
helpful in understanding the characteristics of vascular
endothelial cells, and the mechanisms of cancer invasion
and metastasis.
Methods
Cell lines, animal and reagents
Human lung adencarcinoma cells A549 and human
endothelial-like cells Eahy926 were derived from the
American Type Culture Collection (ATCC). Five- to six-
week-old female BALB/c mice were supplied by our State
Key Laboratory of Biology. Hypoxanthine, aminopterin
and thymidin were purchased from Invitrogen (Carlsbad,
CA, USA). Matrigel, millicell invasion chamber and Milli-
Q water were obtained from Becton Dickinson (Bedford,
MA, USA). Immobiline Dry-Strips (17 cm, pH 3–10 NL),
immobilized pH gradient (IPG) buffer, Dry-Strip cover
fluid, urea, thiourea, ammonium bicarbonate and two-
dimensional sodium dodecyl sulfate/polyacrylamide gel
electrophoresis standards were purchased from BioRad
(Hercules, CA, USA). And dithiothreitol, trifluoroacetic
Proliferation and cell cycle of Eahy926 and A549 cells Figure 1
Proliferation and cell cycle of Eahy926 and A549 cells. (A) Cells number was counted after trypsinization every 24 
hours to draw the growth curves of Eahy926 cells and A549 cells (P > 0.1); (B and C) Cell cycle analysis was performed on 
FACSCalibur flow cytometer. The percentages of cell population in subG1, G1, S or G2/M phases were calculated from histo-
grams by using the CellQuest software; The data represent the mean ± SD of three independent experiments (P > 0.05).Journal of Experimental & Clinical Cancer Research 2009, 28:16 http://www.jeccr.com/content/28/1/16
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acid (TFA), acrylamide, cellulose acetate nitrate (ACN),
glycerol, glycine, iodoacetamide, 3-((3-cholamidopro-
pyl)dimethylammonio)-1-propanesulfonic acid
(CHAPS), bis-hydroxymethyl-oxazoline (Bis), tetrameth-
ylethylenediamine (TEMED), sodium dodecyl sulfate
(SDS), tris-hydroxymethyl-aminomethane (Tris base), 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT), dimethylsulfoxide (DMSO), bovine serum
albumin (BSA) and Coomassie brilliant blue (CBB R-250)
were obtained from Sigma Chemical (St. Louis, MO,
USA).
Cell culture, cell proliferation assay and cycle analysis
Eahy926 and A549 cells were cultured in RPMI1640
media (purchased from Gibco, Langley, OK, USA) con-
taining hypoxanthine, aminopterin and thymidin (HAT),
1% penicillin-streptomycin and 10% fetal calf serum,
incubated at constant 37°C in a 5% CO2-humidified
atmosphere. Then, cells were inoculated in a 24-well plate
at 104 cells per well. Cells were counted daily for 11 days
to draw the growth curves of cell proliferation. Cell cycle
analysis was performed on FACSCalibur flow cytometer
(Elite ESP, Beckman Coulter, Fullerton, CA, USA). The
cells were stained by propidium iodide (PI; BD Pharmin-
gen, San Diego, CA, USA), the percentages of cell popula-
tion in subphases of G0, G1, S or G2/M were calculated
from histograms by using the CellQuest software (BD Sci-
ences, San Jose, CA, USA). The procedure was repeated for
three times.
Cell adhesion, migration and invasion assays
In the cell adhesion assay, 5 × 104 cells were plated on
matrigel-precoated 96-well culture plates. After 1 h of
incubation, nonadherent cells were removed, and 50 μL
of MTT solution (5 mg/ml) was added to each well and
incubated again at 37°C for 4 h. Then 200 μL of DMSO
was added to each well. The optical density (OD) values
were measured at 570 nm using a multi-well scanning
spectrophotometer. Transwell chambers were established
for detecting the ability of cell migration and invasion.
Cell migration was evaluated by Milliwell assays (6.5-mm
diameter, 8-μm pore size polycarbonate membrane). In
the upper chamber 1 × 105 cells in 0.2 mL of serum-free
medium were placed, while in the lower chamber
medium containing 25 μg/ml fibronectin was loaded.
Having migrated to the lower surface of filters, the cells
were stained with hematoxylin solution. After 6 h for the
second incubation, five fields in each well were counted
for number of cells. Three wells were examined for each
condition and cell type, and the experiment was also
repeated for three times. The cell invasion assay was con-
ducted by using 100 ml/well matrigel-precoated 24-well
invasion chambers, with filters coated by extracellular
matrix on the upper surface. Five fields in each well were
counted after incubation for 16 h.
Assay of tumorigenicity
Fourteen of 5 to 6-week-old female BALB/c mice were
divided into two groups (seven mice per group) and inoc-
ulated subcutaneously with 200 μL of Eahy926 cell and
A549 cell suspension (5 × 107/ml) respectively. The
growth of tumor was observed regularly. After two weeks,
the mass of tumor inoculated, the liver and the lungs of
mice were taken, fixed in 40 g/L formaldehyde, and cut
into sections. Finally, slices of these specimens were
stained with regular HE method and observed under
microscope.
Adhesion of Eahy926 and A549 cells with Matrigel in vitro Figure 2
Adhesion of Eahy926 and A549 cells with Matrigel in 
vitro. (A) For adhesion test, extracellular matrix (Matrigel) 
was used. Representative images of Eahy926 and A549 cells 
adhered with the Matrigel after incubation for 1 h; (B) 
Number of adhesive cells with extracellular matrix (Matrigel) 
was measured by MTT assays. The difference in adhesion 
ability between Eahy926 and A549 cells was shown as OD 
value (OD: optical density). Independent experiments were 
measured in triplicate and repeated three times for each cell 
type; Columns, mean of independent experiments measured 
in triplicate and repeated for three independent times; bars, 
SD (P < 0.004).Journal of Experimental & Clinical Cancer Research 2009, 28:16 http://www.jeccr.com/content/28/1/16
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Two-dimensional electrophoresis
Eahy926 and A549 cells (2 × 107/ml) were solubilized in
1 ml of cell lysis solution (8 M urea, 4% CHAPS, 2 mmol/
L TBP, 0.2% ampholyte, traces of bromophenol blue) on
4°C for 20 min. Insoluble material was removed by cen-
trifugation at 15000 rpm at 4°C for 30 min. Protein con-
centration was determined by the method of Bradford.
Samples were frozen at -70°C, and thawed immediately
before use. For 17 cm IPG Ready Strips, 1 mg of protein
was loaded. After rehydrating for 14 h, isoelectric focusing
(IEF) was carried out for 1 h at 200 V, 1 h at 500 V and 1
h at 1000 V continuously; then a gradient was applied
from 1000 to 8000 for 1 h and finally at 8000 V for 8 h to
reach a total of 72 KVh at 20°C. Following IEF separation,
gel strips were incubated in equilibration buffer (50 mM
Tris-HCl, pH 8.8, 6 M urea, 30% glycerol, 2% SDS) with
10 mg/mL DTT for 15 min, followed in equilibration
buffer with 25 mg/mL iodoacetamide for 15 min. Then
strips were loaded on 12.5% SDS-PAGE gels, and electro-
phoresised for 20 min at a constant current of 10 mA and
then at 30 mA per gel until the bromophenol blue reached
the bottom of the gels. Subsequently, the gels were stained
with CBB R-250, and destained with 40% methanol, then
with 10% acetic acid. The experiment was replicated for
five times.
Image analysis and statistical analysis of 2-DE gel
The 12 gels were scanned with the Images Scanner GS800
(BioRad) at 300 dpi resolution. Spot detection, quantifi-
cation, and the analyses of 2-D protein patterns were done
Migration and invasion of Eahy926 and A549 cells with transwell chambers in vitro Figure 3
Migration and invasion of Eahy926 and A549 cells with transwell chambers in vitro. (A) Cell migration was evalu-
ated by Milliwell assays. Cells migrating to the lower surface of filters were stained with hematoxylin solution. Representative 
images of Eahy926 and A549 cells on the lower side of a membrane after incubation for 6 h; (B) The difference in migration 
ability between Eahy926 and A549 cells; Columns, mean of independent experiments measured in triplicate and repeated for 
three independent times; bars, SD (P < 0.01); (C) Invasion assay was conducted by using invasion chambers. Representative 
images of Eahy926 and A549 cells on the lower side of a membrane after incubation for 16 h; (D) The difference in invasion 
capacity between Eahy926 and A549 cells. Columns, mean of independent experiments measured in triplicate and repeated for 
three independent times; bars, SD (P < 0.01).Journal of Experimental & Clinical Cancer Research 2009, 28:16 http://www.jeccr.com/content/28/1/16
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with the PDQuest software (version 7.2, BioRad). Then
the report of quantitative differences between two gel
images was generated. The t-test was performed to com-
pare the relative volume of spots in gels. Significant spots
were selected for protein identification.
MALDI-TOF-MS/MS analysis and database search
Excised gel pieces were destained in 50 mM NH4HCO3
buffer, pH 8.8, containing 50% ACN for 1 h, and dehy-
drated with 100% ACN. Then, gel pieces were rehydrated
in 10 μL trypsin solution (50 mM NH4HCO3, pH 8, con-
taining 12.5 μg/mL) for 1 h. After being incubated at 37°C
overnight, 0.5 μL of incubation buffer was mixed with 0.5
μL of matrix solution (α-cyano-4-hydroxycinnamic acid,
2 mg/mL in 50% ACN, and 0.5% TFA). The sample was
analyzed by Q-TOF Premier Mass Spectrometer (Waters
Micromass, Milford, MA, USA). Ionization was achieved
using a nitrogen laser (337 nm) and acquisitions were per-
formed in a voltage mode. Standard calibration peptide
was applied to the MALDI plate as external calibration of
the instrument, and internal calibration using either
trypsin autolysis ions or matrix was applied post acquisi-
tion for accurate mass determination. These parent ions in
the mass range from 800 to 4000 m/z were selected to
produce MS/MS ion spectra by collision-induced dissoci-
ation (CID). The mass spectrometer data were acquired
and processed using MassLynx 4.1 software (Waters). The
PKL format files were analyzed with a licensed copy of the
MASCOT 2.0 program (MatrixScience, London, UK)
against Swiss-Prot protein database with a peptide toler-
ance of 0.5 Da. Searching parameters were set as follow-
ing: enzyme, trypsin; allowance of up to one missed
cleavage peptide; the peptide mass tolerance, 1.0 Da and
the fragment ion mass tolerance, 0.3 Da; fixed modifica-
tion parameter, carbamoylmethylation; variable modifi-
cation parameters, oxidation; auto hits allowed; results
format as peptide summary report. Proteins were identi-
fied on the basis of two or more peptides, the ions scores
for each one exceeded the threshold, p < 0.05, which indi-
cated identification at the 95% confidence level for those
matched peptides.
Western blot
Western blot was done as previously described. Briefly
speaking, all the cells were lysed in RIPA buffer on ice and
the solutin was centrifugated at 15,000 rpm for 1 h at 4°C.
Proteins were separated by 12% SDS-PAGE, and trans-
ferred to polyvinylidene difluoride membranes. The
membranes were blocked in 5% skimmed milk, and sub-
sequently probed by the primary antibodies. Then the
membranes were washed and incubated with secondary
antibodies conjugated with horseradish peroxidase. The
immunoblot was detected using an enhanced chemilumi-
nescence (ECL) detection system (Western Lighting™,
PerkinElmer Life Science, Boston, USA).
Results
Cell proliferation and cell cycle
MTT assay showed that the doubling time of Eahy926 and
A549 cells was 25.32 h and 27.29 h, respectively (P >
0.05) (Figure 1A). Throughout the cell cycle, there was no
statistical difference in each phase ratio between Eahy926
and A549 cells (P > 0.05) (Figure 1B and 1C).
Adhesion, migration and invasion in vitro
To investigate the adhesion ability of Eahy926 and A549
cells, we counted the number of cells attached to extracel-
lular matrix (Matrigel) by MTT assay. The adhesive ability
of EAhy926 cells was found stronger than that of A549
cells. The OD value of Eahy926 cells was significant
higher than that of A549 cells (0.3236 ± 0.0514 VS 0.2434
± 0.0390, P < 0.004, Figure 2). We sequentially estab-
lished Transwell chambers to detect the ability of cell
migration and invasion. The migration ability of Eahy926
cells was found stronger than that of A549 cells (28.00 ±
2.65 VS 18.00 ± 1.00, P < 0.01, Figure 3A and 3B), while
the invasion ability of Eahy926 cells was significantly
weaker than that of A549 cells (15.33 ± 0.58 VS 26.67 ±
2.52, P < 0.01, Figure 3C and 3D).
Tumorigenicity in vivo
In order to test tumorigenicity of these cells, 1 × 106
Eahy926 cells or A549 cells were subcutaneously (s.c)
Tumorigenicity of Eahy926 and A549 cells in vivo Figure 4
Tumorigenicity of Eahy926 and A549 cells in vivo. (A) 
No tumor mass formed roughly within 14 days after s.c. 
injection of Eahy926 cells; (B) Tumor mass formed roughly 
within 10 days after s.c. injection of A549 cells; (C) On day 
14 after s.c inoculation of Eahy926 cells; tissues collected 
from the inoculative site were identified as inflammatory 
necrosis in the Eahy926 cells group; (D) On day 14 after s.c 
inoculation of A549 cells, classic tumor microstructure was 
found in the A549 cells group and the rate of tumorigenicity 
was 100%.Journal of Experimental & Clinical Cancer Research 2009, 28:16 http://www.jeccr.com/content/28/1/16
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injected into the nude mice. However, no tumor was
observed in any mouse on the 14th day in the Eahy926
cells group (Figure 4A). In the A549 cells group, tumors
formed in each nude mouse on the 10th day after the s.c.
injection (Figure 4B). Tissues collected from the inocula-
tion site were identified as inflammatory necrosis of the
Eahy926 cells group, while in such tissues collected from
the A549 cells group, masses of classic tumor microstruc-
ture were found (Figure 4C and 4D). Moreover, tumor
invasion and metastasis to organs such as the liver and the
lungs were not found by histological examination in both
groups.
Comparative proteomics analysis
Two-dimensional electrophoresis based proteomics
approach was performed to determine the differently
expressed proteins. The images of 2-D gel of both
Eahy926 cells and A549 cells were shown in Figure 5 and
6. Twenty-eight proteins, involved in cell proliferation,
differentiation, signal transduction and so on, were iden-
tified by peptide mass fingerprinting (PMF) and tandem
mass spectrometry (TMS) (Table 1). The PMF and TMS
maps of Annexin A2 were presented in Figure 7. Of the 28
proteins identified above, 15 were found overexpressed in
Eahy926 cells, while 13 were overexpressed in A549 cells.
Table 1: List of identified proteins differentially expressed between Eahy926 and A549 cells
Spot ID Swissa) Gene name Protein name Function Tb) PI Tc) Mr Scored)I d i e)E x f) E/A
A1 P15121 AKR1B1 Aldose reductase (AR) metabolism 6.56 36099 50 TMS down
A2 P04179 SOD2 Superoxide dismutase [Mn] metabolism 8.35 24878 38 TMS down
A3 P11413 G6PD Glucose-6-phosphate 1-
dehydrogenase
metabolism 6.44 59553 276 PMF/TMS down
A4 P29401 TKT Transketolase (TK) metabolism 7.58 68519 119 PMF/TMS down
A5 P50395 GDI2 Rab GDP dissociation 
inhibitor beta
metabolism 6.11 51807 164 PMF/TMS down
A6 P06748 NPM1 Nucleophosim (NPM) metabolism 4.64 32726 116 PMF/TMS down
A7 P43490 NAMPT Nicotinamide 
phosphoribosyltransferase
metabolism 6.69 55772 57 TMS down
A8 P31947 YWHAQ 14-3-3 protein sigma differation/proliferation 4.68 27871 57 TMS down
A9 P07355 ANXA2 Annexin A2 (Annexin?) calcium ion binding 7.56 38677 347 PMF/TMS down
A10 P10809 HSPD1 60 kDa heat shock protein molecular chaperone 5.70 61187 370 PMF/TMS down
A11 O75306 NDUFS2 NADH-ubiquinone 
oxidoreductase
metabolism 7.21 52911 37 TMS down
A12 P60891 PRPS1 Ribose-phosphate 
pyrophosphokinase?
metabolism 6.56 35194 103 PMF/TMS down
A13 P15559 NQO1 NAD(P)H dehydrogenase metabolism 8.91 30905 38 TMS down
E1 P05787 KRT8 Cytokeratin-8 (CK-8) structural 5.52 53540 131 PMF/TMS up
E2 P08238 HSP90AA1 Heat shock protein HSP 90 molecular chaperone 4.94 84875 58 TMS up
E3 P07858 CTSB Cathepsin B precursor 
(Cathepsin B)
migration/inv-asion 5.28 38766 84 TMS up
E4 P62333 PSMC6 26s protease regulatory 
subunit
metabolism 7.10 44430 76 TMS up
E5 P05783 KRT18 Cytokeratin-18 (CK18) structural 5.34 47897 107 PMF/TMS up
E6 P48643 CCT5 T-complex protein (TCP-1) 
(CCT)
molecular chaperone 5.45 60089 82 TMS up
E7 P08670 VIM Vimentin structral 5.06 53545 38 TMS up
E8 P68032 ACTC Alpha-cardiac action migration/inv-asion 5.23 42334 57 TMS up
E9 P00491 NP Purine nucleoside 
phosphorylase (PNP)
metabolism 6.45 32325 64 TMS up
E10 P00338 LDHA L-lactate dehydrogenase A 
(LDH-A)
metabolism 8.46 36819 41 TMS up
E11 P22626 HNRPA2B1 hnRNP A2/B1 differation/proliferation 8.97 37464 173 PMF/TMS up
E12 P11021 HSPA5 78 kDa glucose-regulated 
protein
molecular chaperone 5.07 72402 299 PMF/TMS up
E13 P63244 GNB2L1 Guanine nucleotide-bingding 
protein
signal transduction 7.56 35380 199 PMF/TMS up
E14 P31948 STIP1 Stress-induced-
phosphoprotein 1
molecular chaperone 6.40 63227 30 TMS up
E15 P26641 EEF1G Elongation factor 1-gamma structural 6.27 50298 113 PMF/TMS up
a) Swiss: SWISS-PROT accession number; b) T pI: theoretical isoelectric point of the matching protein; c) T Mr: theoretical relative molecular mass 
of the matching protein; d) Score: the score of PMF and TMS; e) Idi: identification method; TMS: tandem mass spectrometry; PMF: peptide mass 
fingerprinting; f) Ex E/A: expression level in Eahy926/A549 cellsJournal of Experimental & Clinical Cancer Research 2009, 28:16 http://www.jeccr.com/content/28/1/16
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Western blot verification
To verify the expression of HSP60 protein in both A549
and Eahy926 cells, western blot was performed. Expres-
sion of HSP60 protein was identified in both A549 cells
and Eahy926 cells, and overexpression of this protein was
found in the former (Figure 8). The result was consistent
with the findings on 2-D gels about HSP60 protein.
Discussion
Interactions of cancer cells with vascular endothelial cells
are very complicated [7,8]. Cancer cells and endothelial
cells communicate with each other and influence angio-
genesis through the formation of gap junctions [9]. More-
over, cancer cells can fuse with endothelial cells to form
hybrid cells spontaneously both in vivo and in vitro. The
hybrid cells are viable and able to undergo mitosis.
Importantly, after fusion with endothelial cells, cancer
cells acquire some of the characteristics of endothelial
cells temporarily or permanently, which is involved in
promotion of tumor invasion and metastasis.
Human endothelial-like Eahy926 cell line was derived by
fusing human umbilical vein endothelial cells with the
permanent human cell line A549. Hybrid cell line
Eahy926 had more chromosomes than either of its pro-
genitor cell types had. However, there were few researches
on the difference in biological behaviors and expression
of proteins between the hybrid cells and its parent cells
recently. Here we obtained several results regarding the
difference in biological behaviors and protein expression
Close-up image of partial differential expression of protein  spots between Eahy926 and A549 cells Figure 6
Close-up image of partial differential expression of 
protein spots between Eahy926 and A549 cells. Pro-
tein spot discrepancies were arrowed and marked with 
number. Each bar graph showed expression level of protein 
spots in Eahy926 and A549 cells.
Analysis of differentially expressed proteins by 2-DE (two-dimensional electrophoresis) Figure 5
Analysis of differentially expressed proteins by 2-DE (two-dimensional electrophoresis). Two-dimensional electro-
phoresis based proteomics approaches were performed to determine the proteins expressed differently. Representative 2-DE 
gels of Eahy926 and A549 cells. Differential expression protein spots were labeled with numbers.Journal of Experimental & Clinical Cancer Research 2009, 28:16 http://www.jeccr.com/content/28/1/16
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between the hybrid cells Eahy926 and its parent cells
A549. Cell counting and cycle analysis assays showed that
the proliferation ability of Eahy926 cells was similar to
that of A549 cells. Why did not significant difference exist
for cell proliferation and cell cycle in both cell lines? The
reason for this may be as following. Firstly, with fused
cancer cells, hybrid cells could acquire malignant cell pro-
liferation characteristics of cancer [3,5,10]. Secondly, the
transformation of endothelial cells after fusion might
cause an alteration in their receptors and signal transduc-
tion systems, which also affect their affinity for and
responses to growth factors [11].
MS spectra of tryptic peptides from spot A-9 (Annexin A2) Figure 7
MS spectra of tryptic peptides from spot A-9 (Annexin A2). (A) Peptide mass fingerprinting (PMF) of the trypsin-
cleaved spot A-9. The sequence of Annexin A2 protein was represented by single-letter code for amino acids on the top right 
corner of the image and it was exhibited by red bold. Sequence coverage: 26%; (B) MS-MS sequence analysis of one of the par-
ent ions, m/z value 2065.0024. The matched sequence was identified as RAEDGSVIDYELIDQDAR.Journal of Experimental & Clinical Cancer Research 2009, 28:16 http://www.jeccr.com/content/28/1/16
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In this study, twenty-eight differentially expressed pro-
teins, related to cell proliferation, differentiation, apopto-
sis, invasion and metastasis, were identified by
proteomics technologies in the cell lines. At the same
time, it was found that the adhesion ability with Matrigel
of Eahy926 cells were stronger. In fact, the long fusiform
morphology of Eahy926 cells was similar to the endothe-
lial cells, which was associated with the higher adhesion
ability. In addition, the up-regulation of cell surface adhe-
sion molecules such as ICAM-1 and VCAM-1 also
enhanced the cells adhesion [12].
In this paper, we also found that the migration of
Eahy926 cells was more but the invasion was less than
those of the parental cell line, and that xenograft tumor
failed to form in the nude mouse. By coincidence, other
researchers also found that the invasion ability of
Eahy926 cells was weaker than that of HT1080 fibrosar-
coma and C8161 melanoma cells, but was stronger than
that of umbilical vein endothelial cells [13]. Actually,
molecular biological mechanisms on this phenomenon
have not been elucidated completely. Annexin A2, a Ca2+-
binding protein, has a function in promoting tumor cells
invasion and metastasis through its interaction with
matrix proteins [14,15]. Annexin A2 was found down-reg-
ulated in Eahy926 cells (Table 1, Figure 6). Reduction of
annexin A2 resulted in the weaker invasion and tumori-
genesis ability of Eahy926 cells. CK18, CK8 and cathepsin
B were involved in cell malignant transformation and the
destruction of basement membranes by degrading colla-
gen and laminin, promoting tumor migration [16-19].
These proteins were found up-regulated in Eahy926 cells
(Table 1, Figure 6). Therefore, the higher migration ability
of Eahy926 cells shown in this study could be accounted
for partially at the protein level. However, it was difficult
to explain all the biological behaviors only by the proteins
founding. For instance, GRP78, as a heat shock protein,
was implicated in protecting tumor cells from cytotoxic
damage and apoptosis. Over-expressed GRP78 has been
correlated with tumor invasion and metastasis in the
xenograft nude mouse model [20-22]. Although GRP78
was up-regulated in this study, Eahy926 cells had the
weaker invasion ability than A549 cells had and failed to
form xenograft tumor in nude mice. There were many fac-
tors influencing the cell's biological behaviors. Several
researches suggested that many hybrid cells, derived from
fusion of cancer cells with normal cells, had the weaker
tumorigenesis [23,24]. But, hybridoma cells used in pro-
ducing monoclonal antibodies had stronger tumorigene-
sis. Additionally, another hybrid cell line, derived from
fusion of human cervical carcinoma cells HeLa with
human diploid fibroblasts, was also found to be non-
tumorigenic completely in vivo [25]. The probable causes
lay in transferring of the tumor suppressor gene and the
different responses to the growth regulatory signals
[26,27]. In the present study, we investigated malignant
biological behaviors and protein expression of hybrid cell
line Eahy926 comparatively. Having considered the com-
plex formation process of hybrid cells, further study
should be made to explore the complex interactions of
tumor cells with endothelial cells. This would not only
contribute to the elucidation of the accurate processes of
tumor angiogenesis, invasion and metastasis, but also be
helpful in screening more molecular targets for the devel-
opment of novel therapeutic approaches.
Conclusion
Our study suggested that the proliferation ability of
Eahy926 cells was similar to that of A549 cells, but the
ability in adhesion and migration of Eahy926 cells was
higher. In addition, Eahy926 cells had weaker ability of
invasion and could not form tumor mass. Furthermore,
there were many differently expressed proteins between
hybrid cell line Eahy926 cells and A549 cells, which might
partly account for some of the differences between their
biological behaviors at the molecular level. These results
may help to understand the processes of tumor angiogen-
esis, invasion and metastasis, and to search for screening
method for more targets for tumor therapy in future.
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Western blot analysis of Hsp60 Figure 8
Western blot analysis of Hsp60. Western blot was per-
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